What Are Bioregulator Peptides? An Introduction to Khavinson Peptides
PeptaBase Research Review | 2026-02-28
Origin and Background
Bioregulator peptides came from the St. Petersburg Institute of Bioregulation and Gerontology starting in the 1970s. Vladimir Khavinson (a gerontologist) theorized that short peptides from organ extracts could control gene expression in a tissue-specific way.
The original work was military/institutional: Khavinson used organ extracts to help people recover from stress. Over time, the focus shifted to shorter, synthetic peptides with clearer properties.
What Bioregulator Peptides Are
Bioregulator peptides are 2, 3, or 4-amino acids long-incredibly short. Epithalon is 4 amino acids. Vilon is 2. Their tiny size is key to the theory.
The claim: peptides this small can cross cell membranes and bind DNA directly. They'd act as gene-control switches that wear out with age and can be restored by adding the peptides back.
This is a bold claim-most peptides work on surface receptors, not inside the nucleus touching DNA. Depending on which studies you believe, this mechanism is either plausible or unproven.
Tissue-Specific Mechanism Hypothesis
The theory has tissue specificity: a peptide from thymus (like Thymogen) controls immune cells. A peptide from pineal (like Epithalon) controls the brain and pineal gland.
The reasoning: the sequence matches DNA regulatory regions that are unique to that tissue type. There's some computational support for this, but actual proof in living organisms is thin.
Common Examples
Several bioregulator peptides have received the most research attention:
- Epithalon (AEDG) - pineal gland origin; most studied for telomerase activation and longevity-related outcomes
- Thymalin - thymus-derived polypeptide precursor; studied for immune modulation in aging
- Thymogen (Glu-Trp) - synthetic dipeptide from thymus research; immune signaling
- Pinealon (Glu-Asp-Arg) - tripeptide studied for neuroprotective applications
- Cortagen (Ala-Glu-Asp-Pro) - lung and brain-related research
- Vilon (Lys-Glu) - broad immune and aging research applications
Why English-Language Coverage Is Limited
Most bioregulator research is in Russian journals and Soviet archives, so it's not in PubMed or major databases. Language barriers and Cold War-era institutional secrecy made it hard to access.
Also, the claims (gene control, longevity) seemed too radical, so Western scientists didn't bother replicating. Result: lots of published research, but almost no independent verification.
Evidence Context
Be aware: almost all the evidence comes from one lab. Most studies haven't been replicated independently. The mechanisms sound plausible but haven't been validated by Western regulatory standards.
That said, aging researchers are starting to take these compounds seriously as aging biology becomes mainstream science.
--- For research use only. Not medical advice.